310 related articles for article (PubMed ID: 15341595)
101. The expression pattern of nitric oxide-sensitive guanylyl cyclase in the rat heart changes during postnatal development.
Behrends S; Mietens A; Kempfert J; Koglin M; Scholz H; Middendorff R
J Histochem Cytochem; 2002 Oct; 50(10):1325-32. PubMed ID: 12364565
[TBL] [Abstract][Full Text] [Related]
102. Soluble guanylate cyclase modulates alveolarization in the newborn lung.
Bachiller PR; Cornog KH; Kato R; Buys ES; Roberts JD
Am J Physiol Lung Cell Mol Physiol; 2013 Oct; 305(8):L569-81. PubMed ID: 23934926
[TBL] [Abstract][Full Text] [Related]
103. Interactions of soluble guanylate cyclase with a P-site inhibitor: effects of gaseous heme ligands, azide, and allosteric activators on the binding of 2'-deoxy-3'-GMP.
Makino R; Yazawa S; Hori H; Shiro Y
Biochemistry; 2012 Nov; 51(46):9277-89. PubMed ID: 23106307
[TBL] [Abstract][Full Text] [Related]
104. Ammonia affects the activity and expression of soluble and particulate GC in cultured rat astrocytes.
Konopacka A; Freśko I; Piaskowski S; Albrecht J; Zielińska M
Neurochem Int; 2006; 48(6-7):553-8. PubMed ID: 16517024
[TBL] [Abstract][Full Text] [Related]
105. Localization of cGMP immunoreactivity and of soluble guanylyl cyclase in antennal sensilla of the hawkmoth Manduca sexta.
Stengl M; Zintl R; De Vente J; Nighorn A
Cell Tissue Res; 2001 Jun; 304(3):409-21. PubMed ID: 11456418
[TBL] [Abstract][Full Text] [Related]
106. YC-1 induces lipid droplet formation in RAW 264.7 macrophages.
Tsui L; Chang SF; Huang HP; Fong TH; Wang IJ
J Biomed Sci; 2016 Jan; 23():2. PubMed ID: 26767504
[TBL] [Abstract][Full Text] [Related]
107. Mapping Soluble Guanylyl Cyclase and Protein Disulfide Isomerase Regions of Interaction.
Heckler EJ; Kholodovych V; Jain M; Liu T; Li H; Beuve A
PLoS One; 2015; 10(11):e0143523. PubMed ID: 26618351
[TBL] [Abstract][Full Text] [Related]
108. Nitric oxide activation of soluble guanylyl cyclase reveals high and low affinity sites that mediate allosteric inhibition by calcium.
Kazerounian S; Pitari GM; Ruiz-Stewart I; Schulz S; Waldman SA
Biochemistry; 2002 Mar; 41(10):3396-404. PubMed ID: 11876648
[TBL] [Abstract][Full Text] [Related]
109. Cerebellar localization of the NO-receptive soluble guanylyl cyclase subunits-alpha(2)/beta (1) in non-human primates.
Bidmon HJ; Mohlberg H; Habermann G; Buse E; Zilles K; Behrends S
Cell Tissue Res; 2006 Dec; 326(3):707-14. PubMed ID: 16819625
[TBL] [Abstract][Full Text] [Related]
110. Human soluble guanylate cyclase: functional expression and revised isoenzyme family.
Zabel U; Weeger M; La M; Schmidt HH
Biochem J; 1998 Oct; 335 ( Pt 1)(Pt 1):51-7. PubMed ID: 9742212
[TBL] [Abstract][Full Text] [Related]
111. Effects of the JNK inhibitor anthra[1,9-cd]pyrazol-6(2H)-one (SP-600125) on soluble guanylyl cyclase alpha1 gene regulation and cGMP synthesis.
Krumenacker JS; Kots A; Murad F
Am J Physiol Cell Physiol; 2005 Oct; 289(4):C778-84. PubMed ID: 15888553
[TBL] [Abstract][Full Text] [Related]
112. Nitric oxide-induced conformational changes in soluble guanylate cyclase.
Underbakke ES; Iavarone AT; Chalmers MJ; Pascal BD; Novick S; Griffin PR; Marletta MA
Structure; 2014 Apr; 22(4):602-11. PubMed ID: 24560804
[TBL] [Abstract][Full Text] [Related]
113. An enzyme-linked receptor mechanism for nitric oxide-activated guanylyl cyclase.
Roy B; Halvey EJ; Garthwaite J
J Biol Chem; 2008 Jul; 283(27):18841-51. PubMed ID: 18463095
[TBL] [Abstract][Full Text] [Related]
114. Role of conformational changes in the heme-dependent regulation of human soluble guanylate cyclase.
Kosarikov DN; Lee JM; Uversky VN; Counts Gerber N
J Inorg Biochem; 2001 Dec; 87(4):267-76. PubMed ID: 11744065
[TBL] [Abstract][Full Text] [Related]
115. The NO signaling pathway differentially regulates KCC3a and KCC3b mRNA expression.
Di Fulvio M; Lauf PK; Adragna NC
Nitric Oxide; 2003 Nov; 9(3):165-71. PubMed ID: 14732340
[TBL] [Abstract][Full Text] [Related]
116. Cerebral expression of the alpha2-subunit of soluble guanylyl cyclase is linked to cerebral maturation and sensory pathway refinement during postnatal development.
Bidmon HJ; Starbatty J; Görg B; Zilles K; Behrends S
Neurochem Int; 2004 Nov; 45(6):821-32. PubMed ID: 15312976
[TBL] [Abstract][Full Text] [Related]
117. Guanylyl cyclase: NO hits its target.
Russwurm M; Koesling D
Biochem Soc Symp; 2004; (71):51-63. PubMed ID: 15777012
[TBL] [Abstract][Full Text] [Related]
118. Distribution of soluble guanylyl cyclase in the rat brain.
Ding JD; Burette A; Nedvetsky PI; Schmidt HH; Weinberg RJ
J Comp Neurol; 2004 May; 472(4):437-48. PubMed ID: 15065118
[TBL] [Abstract][Full Text] [Related]
119. Alterations in soluble guanylate cyclase content and modulation by nitric oxide in liver disease.
Rodrigo R; Montoliu C; Chatauret N; Butterworth R; Behrends S; Del Olmo JA; Serra MA; Rodrigo JM; Erceg S; Felipo V
Neurochem Int; 2004 Nov; 45(6):947-53. PubMed ID: 15312989
[TBL] [Abstract][Full Text] [Related]
120. Interaction of soluble guanylate cyclase with YC-1: kinetic and resonance Raman studies.
Denninger JW; Schelvis JP; Brandish PE; Zhao Y; Babcock GT; Marletta MA
Biochemistry; 2000 Apr; 39(14):4191-8. PubMed ID: 10747811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
